Cereno Scientific reports insider share purchases
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announces that insider share purchases have been completed. Joakim Söderström, chairman of the Board of Directors of Cereno Scientific, has purchased a total of 78,105 B-shares, privately and through a wholly owned company. Additionally, Jeppe Øvlesen, director of the Board of Directors of Cereno Scientific, has purchased a total of 30,234 B-shares, and Sten R. Sörensen, CEO of Cereno Scientific, has purchased